传奇生物的管线正开始变得重要（纳斯达克：LEGN）
· seekingalpha.com
传奇生物正从一家资本密集型生物技术公司转型为以CARVYKTI驱动的盈利性商业细胞疗法公司。了解为何LEGN股票值得买入。
I think this 2Q26 call really goes to show that Legend Biotech Corporation ( LEGN ) is hitting an inflection point. That is, they're transitioning from a capita...